10-Q: RYAM Reports Steep Q2 Loss Amid Tariff Headwinds

Sentiment:

Quarterly Report


Rayonier Advanced Materials Inc. reported a significant net loss of $363.2 million in Q2 2025, primarily due to a $337 million non-cash write-off of Canadian deferred tax assets, alongside declining sales and operational challenges.

Delay expectedThe City of Fernandina Beach recently denied the site plan application for the proposed bioethanol facility, leading the company to pursue all available legal remedies, which could delay the project.
Capital raiseSecured €30 million from SWEN Impact Fund for Transition 3 (SWEN) for up to a 20% preferred equity interest in BioNova, with €15 million received in 2024 and subsequent funding contingent on project milestones.Entered into a credit agreement for up to €37 million in sevenand eight-year secured term loan tranches for BioNova, with no amounts outstanding as of June 28, 2025.
Worse than expectedReported a net loss of $363.2 million for the quarter, a substantial decline from a net income of $11.4 million in the prior year, primarily due to a $337 million non-cash write-off of Canadian deferred tax assets.Net sales decreased by 19% for the quarter and 14% for the six months, indicating significant revenue contraction.Gross margin percentage declined from 11.5% to 7.1% for the quarter, reflecting reduced profitability.Operating income shifted from a profit of $28.2 million to a loss of $1.3 million for the quarter, and from a profit of $45.3 million to a loss of $16.4 million for the six months.Cash provided by operating activities decreased by $89 million for the six-month period, and adjusted free cash flow turned negative by $52 million, indicating poor cash generation.The debt to capital ratio worsened to 69% from 51%, signaling increased financial risk.

Summary

  • Reported a net loss attributable to RYAM of $363.2 million for the three months ended June 28, 2025, a significant decline from a net income of $11.4 million in the prior year period.
  • Net sales decreased by $79 million, or 19%, to $340 million for the quarter, and by $111 million, or 14%, to $696 million for the six months ended June 28, 2025, compared to the same prior year periods.
  • Gross margin declined to 7.1% for the quarter (from 11.5%) and 6.9% for the six months (from 10.5%).
  • Operating income shifted to a loss of $1.3 million for the quarter (from $28.2 million income) and a loss of $16.4 million for the six months (from $45.3 million income).
  • The net loss was primarily driven by a $337 million non-cash write-off of Canadian deferred tax assets (DTAs) in the second quarter of 2025, due to an expected cumulative adjusted pre-tax loss in Canada.
  • Cash provided by operating activities decreased significantly to $9.4 million for the six months ended June 28, 2025, from $98.9 million in the prior year period.
  • Adjusted free cash flow was negative $52 million for the six months, down from positive $69 million in the prior year period.
  • Total debt increased to $745.7 million as of June 28, 2025, from $729.8 million at December 31, 2024, leading to a debt to capital ratio of 69% (up from 51%).
  • Incurred $12 million in non-cash environmental reserve charges in the first quarter of 2025, related to remediation sites in Port Angeles, Washington, and Augusta, Georgia.

Sentiment

Score: 2

Explanation: The company reported a massive net loss primarily due to a significant non-cash deferred tax asset write-off, coupled with substantial declines in sales, gross margin, operating income, and cash flow from operations. While management highlights some improving trends and future strategic growth initiatives, the current financial performance is severely negative, and the DTA write-off indicates a challenging outlook for Canadian operations.

Positives

  • Order trends in Cellulose Specialties have improved month over month since May, with operational performance across cellulose facilities remaining broadly stable.
  • Biomaterials strategy is advancing, with the bioethanol facility in France operational since Q1 2024 and the lignosulfonate powder plant in France re-started in Q1 2025.
  • Received Generally Recognized As Safe (GRAS) status for the prebiotics product from the U.S. Food and Drug Administration in July 2025.
  • Lower indefinite suspension charges and lower variable compensation costs partially offset financial declines.
  • New collective bargaining agreements for the Jesup plant employees were ratified in July 2025, effective through June 30, 2029, ensuring labor stability.

Negatives

  • Reported a substantial net loss of $363.2 million for the quarter and $395.2 million for the six months, primarily due to a $337 million non-cash write-off of Canadian deferred tax assets.
  • Significant declines in net sales, gross margin, and operating income across most segments.
  • Cash provided by operating activities decreased by $89 million, and adjusted free cash flow turned negative by $52 million for the six-month period.
  • Debt to capital ratio worsened to 69% from 51%, indicating increased leverage.
  • Sales volumes declined across all segments due to tariff impacts, destocking, and operational challenges, including a labor strike at the Tartas cellulose plant.
  • Paperboard and High-Yield Pulp segments experienced soft demand, declining prices, and increased input costs, leading to planned production idling in Q3.
  • Incurred $12 million in non-cash environmental reserve charges in Q1 2025, increasing environmental liabilities.

Risks

  • Chinese retaliatory tariffs continue to disrupt global fluff market dynamics, creating a mismatch between supply and demand for Cellulose Commodities.
  • Softer demand in Paperboard and High-Yield Pulp segments due to continued economic uncertainty, weaker customer demand, and oversupply in the Chinese market.
  • Increased competitive activity in Paperboard from new U.S. competitor capacity and European Union imports.
  • Raw material input and logistics costs are expected to increase moderately year-over-year for Cellulose Specialties and Cellulose Commodities.
  • Potential continued foreign exchange headwinds from a weaker U.S. dollar impacting corporate costs.
  • Significant environmental liabilities, with potential additional costs up to approximately $77 million beyond established liabilities, due to changes in laws, regulations, and remediation costs.
  • Exposure to market risks, including changes in interest rates (a hypothetical 1% change in variable rates would result in a $7 million annual change in interest expense), currency fluctuations, and commodity prices.
  • The denial of the site plan application for the Fernandina Beach bioethanol facility by the City of Fernandina Beach poses a legal and project execution risk.

Future Outlook

The company expects to meaningfully grow EBITDA over the two years following 2025 by increasing Cellulose Specialties sales volume through expected market demand growth, expanding Cellulose Specialties margins via price increases and high-return cost reduction projects, and accelerating high-return investments in Biomaterials. Cellulose Specialties sales prices are anticipated to increase mid-single digits in 2025, while volumes are expected to decline high-single digits due to tariffs and destocking. Biomaterials projects, including a bioethanol facility in Fernandina Beach (despite a recent site plan denial), crude tall oil facilities, and a prebiotics facility, are being pursued with final investment decisions on several expected in 2025. Production in Cellulose Commodities is being shifted towards non-fluff products due to Chinese tariffs. Paperboard and High-Yield Pulp segments anticipate continued soft demand, declining prices, and rising input costs, leading to planned production idling in Q3 2025. Corporate costs are expected to be higher in 2025 due to environmental charges and foreign exchange headwinds, partially offset by lower spending post-ERP implementation.

Management Comments

  • "While these near-term pressures weighed on second quarter results, they are largely considered to have peaked in the period."
  • "Since May, order trends in Cellulose Specialties have improved month over month and operational performance across our cellulose facilities has remained broadly stable."
  • "With signs of normalization emerging, RYAM is positioned to rebuild momentum in the second half of the year."
  • "Looking ahead, we expect to meaningfully grow EBITDA over the two years following 2025, supported by focused efforts to increase Cellulose Specialties sales volume from the expected market demand growth, expand Cellulose Specialties margins by increasing prices and investing in high return cost reduction projects and accelerate high-return investments in Biomaterials."
  • "These actions are core to RYAMs long-term strategy."
  • "We remain committed to disciplined capital allocation."

Industry Context

The company's performance is significantly impacted by global trade disruptions, particularly Chinese retaliatory tariffs affecting the global fluff market and creating supply-demand mismatches for Cellulose Commodities. The Paperboard segment faces increased competitive activity from new U.S. competitor capacity and European Union imports. The High-Yield Pulp market is experiencing oversupply in China, contributing to declining sales prices and volumes. Conversely, demand for certain other cellulose specialties grades remains strong, supported by tight global supply conditions.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
System ImplementationImplemented a new financial accounting system for product costing in January 2025, leading to updated processes, procedures, and controls.January 2025Management is refining and further evaluating these control changes as part of the assessment of control design and effectiveness throughout 2025. No material effect on internal control over financial reporting for the quarter ended June 28, 2025.

Legal Proceedings

  • Engaged in various legal and regulatory actions and proceedings and has been named as a defendant in various lawsuits and claims arising in the ordinary course of business.
  • The company is currently evaluating the impact of new U.S. tax reform legislation enacted on July 4, 2025, on its consolidated financial statements.
  • Pursuing all available legal remedies after the City of Fernandina Beach denied the site plan application for the proposed bioethanol facility, believing the City erred in its determination.

Related Party Transactions

  • The company is a guarantor of LTF's (LignoTech Florida LLC, 45% owned by the company, 55% by Borregaard ASA) financing agreements, with a proportional guarantee of $26 million at June 28, 2025.

Stakeholder Impact

  • Shareholders: Experienced a significant net loss and negative EPS, a substantial decrease in stockholders' equity, and the quarterly common stock dividend remains suspended. The company does not expect to utilize the remaining $60 million in unused share buyback authorization.
  • Employees: Incurred severance and other employee costs related to the indefinite suspension of the Temiscaming cellulose plant. New collective bargaining agreements were ratified for the Jesup plant, providing labor stability through June 2029.
  • Customers: Facing soft demand, accelerated destocking, and tariff-driven impacts in certain segments, leading to lower sales volumes.
  • Creditors: Long-term debt increased, and the debt to capital ratio worsened, though the company remains in compliance with all debt covenants.
  • Suppliers: The company has ongoing purchase obligations primarily for natural gas, electricity, and wood chips.

Next Steps

  • Rebuild momentum in the second half of 2025.
  • Meaningfully grow EBITDA over the two years following 2025.
  • Increase Cellulose Specialties sales volume from expected market demand growth.
  • Expand Cellulose Specialties margins by increasing prices and investing in high-return cost reduction projects.
  • Accelerate high-return investments in Biomaterials.
  • Continue to advance engineering plans and explore potential commercial agreements for the Fernandina Beach bioethanol facility.
  • Evaluate investments in crude tall oil facilities in Jesup, Georgia, and Tartas, and a prebiotics facility at the Jesup plant, working on permitting, engineering, and commercial agreements.
  • AGE is actively evaluating the construction and financing requirements for the new green electricity facility adjacent to the Jesup plant.
  • Expect to make final investment decisions on several Biomaterials projects in 2025.
  • Adjust production mix in Cellulose Commodities to mitigate the impact of direct tariffs and related second-order effects.
  • Idling Paperboard production for two weeks during the third quarter to align inventory levels with demand and preserve cash flow.
  • Idling High-Yield Pulp production for three weeks during the third quarter to proactively manage inventory levels and preserve cash flow.
  • Continue to take proactive steps to manage production and costs in High-Yield Pulp.

Key Dates

DateDescription
August 2021Completion of the sale of lumber and newsprint facilities and certain related assets in Canada.
December 2023FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures.
August 2023FASB issued ASU 2023-05 Business CombinationsJoint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement.
July 2024Indefinite suspension of operations at the Temiscaming cellulose plant began.
November 2024BioNova issued 111,111 preferred shares to SWEN for a redeemable noncontrolling interest; entered into a credit agreement for up to €37 million BioNova Term Loan.
January 1, 2025Adoption of ASU 2023-05; reorganization of High Purity Cellulose operating segment into Cellulose Specialties, Cellulose Commodities, and Biomaterials.
Q1 2025Bioethanol facility in France became operational; lignosulfonate powder plant in France re-started.
March 2025Performance-based awards granted in 2022 were settled.
June 28, 2025End of the quarterly reporting period.
June 30, 2025Collective bargaining agreements covering approximately 640 unionized employees at the Jesup plant expired.
July 4, 2025United States enacted tax reform legislation.
July 2025Received GRAS status for prebiotics product from the U.S. Food and Drug Administration.
July 18, 2025New collective bargaining contracts for the Jesup plant were ratified, effective through June 30, 2029.
August 4, 2025Date for common stock outstanding count (67,000,882 shares).
August 6, 2025Date of filing the Form 10-Q.
2025Expected final investment decisions on several Biomaterials projects.
Early 2027Expected cash impact associated with the Augusta, Georgia remediation site charge.
Not before 2028Expected commencement of cash expenditures for the Port Angeles, Washington remediation site.
October 2029Maturity date for the $700 million original aggregate principal amount variable rate term loan.
November 2029Maturity date for the $175 million 5-year senior secured asset-based revolving credit facility.
November 2031Maturity date for a tranche of the BioNova Term Loan.
November 2032Maturity date for a tranche of the BioNova Term Loan.

Recommendation

strong sell

The company reported a substantial net loss of $363.2 million for the quarter, primarily driven by a $337 million non-cash write-off of Canadian deferred tax assets, indicating a severely impaired outlook for future Canadian earnings. This, combined with significant year-over-year declines in net sales (down 19%), gross margin (down 51%), and a shift to an operating loss, paints a dire financial picture. Cash flow from operations also plummeted by $89 million. While management points to some improving order trends and strategic biomaterials investments, the immediate financial performance is exceptionally weak, and the increased debt-to-capital ratio further raises concerns about financial health. The combination of poor current results, a major non-cash impairment, and ongoing market headwinds suggests significant downside risk for investors.

Keywords

Rayonier Advanced Materials, RYAM, SEC Filing, 10-Q, Quarterly Report, Financial Results, Net Loss, Deferred Tax Assets, Cellulose Specialties, Biomaterials, Paperboard, High-Yield Pulp, Tariffs, Sustainable Aviation Fuel, Bioethanol, Environmental Remediation, Corporate Governance, Debt, Cash Flow

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.